![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 3
Zeitschriftenartikel
Frontzek, Fabian; Ziepert, Marita; Nickelsen, Maike; Altmann, Bettina; Glass, Bertram; Haenel, Mathias; Truemper, Lorenz; Held, Gerhard; Bentz, Martin; Borchmann, Peter; Dreyling, Martin; Viardot, Andreas; Kroschinsky, Frank P.; Metzner, Bernd; Staiger, Annette M.; Horn, Heike; Ott, German; Rosenwald, Andreas; Loeffler, Markus; Lenz, Georg und Schmitz, Norbert
(2021):
Rituximab plus high-dose chemotherapy (MegaCHOEP) or conventional chemotherapy (CHOEP-14) in young, high-risk patients with aggressive B-cell lymphoma: 10-year follow-up of a randomised, open-label, phase 3 trial.
In: Lancet Haematology, Bd. 8, Nr. 4, E267-E277
Pfreundschuh, Michael; Murawski, Niels; Zeynalova, Samira; Ziepert, Marita; Löffler, M.; Hänel, Matthias; Dierlamm, Judith; Keller, Ulrich; Dreyling, Martin; Truemper, Lorenz; Frickhofen, Norbert; Hünerlitürkoglu, Ali-Nuri; Schmitz, Norbert; Pöschel, Viola; Rixecker, Tanja; Berdel, Christian; Rübe, Christian; Held, Gerhard und Zwick, Carsten
(2017):
Optimization of rituximab for the treatment of DLBCL: increasing the dose for elderly male patients.
In: British Journal of Haematology, Bd. 179, Nr. 3: S. 410-420
Schlenk, Richard F.; Lübbert, Michael; Benner, Axel; Lamparter, Alexander; Krauter, Jürgen; Herr, Wolfgang; Martin, Hans; Salih, Helmut R.; Kündgen, Andrea; Horst, Heinz-A.; Brossart, Peter; Götze, Katharina; Nachbaur, David; Wattad, Mohammed; Köhne, Claus-Henning; Fiedler, Walter; Bentz, Martin; Wulf, Gerald; Held, Gerhard; Hertenstein, Bernd; Salwender, Hans; Gaidzik, Verena I.; Schlegelberger, Brigitte; Weber, Daniela; Döhner, Konstanze; Ganser, Arnold und Döhner, Hartmut
(2016):
All-trans retinoic acid as adjunct to intensive treatment in younger adult patients with acute myeloid leukemia: results of the randomized AMLSG 07-04 study.
In: Annals of Hematology, Bd. 95, Nr. 12: S. 1931-1942